Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Pelkonen

Showing results (151-160 of 158) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 158 results.
Acta Diabetologica|January 1, 1992
Cyclosporin reduces renal prostanoid excretion in type 1 diabetic patientsV A Koivisto, M Leirisalo-Repo, R Pelkonen, et al.
Acta Endocrinologica|July 1, 1989
Endocrine abnormalities in patients with adrenal tumours incidentally discovered on computed tomographyA Virkkala, M Välimäki, R Pelkonen, et al.
Duodecim; Laaketieteellinen Aikakauskirja|January 1, 1980
[Comparative study on the effects of carbimazole and propranolol in 131I-therapy of hypothyroidism]A Aro, J K Huttunen, E Ikkala, et al.
Diabetologia|August 1, 1984
Remissions in newly diagnosed type 1 (insulin-dependent) diabetes: influence of interferon as an adjunct to insulin therapyV A Koivisto, A Aro, K Cantell, et al.
Acta Endocrinologica|March 1, 1981
Comparison of propranolol and carbimazole as adjuncts to iodine-131 therapy of hyperthyroidismA Aro, J K Huttunen, B A Lamberg, et al.
Diabetes Care|July 1, 1993
Seven years of remission in a type I diabetic patientV A Koivisto, M Leirisalo-Repo, P Ebeling, et al.
Current Drug Metabolism|February 3, 2007
Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liverZoe E Barter, Martin K Bayliss, Philip H Beaune, et al.
Regulatory Toxicology and Pharmacology : RTP|November 30, 2013
PBTK modelling platforms and parameter estimation tools to enable animal-free risk assessment: recommendations from a joint EPAA--EURL ECVAM ADME workshopJos G Bessems, George Loizou, Kannan Krishnan, et al.
Pageof 16

Showing results (151-160 of 158) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 158 results.
Acta Diabetologica|January 1, 1992
Cyclosporin reduces renal prostanoid excretion in type 1 diabetic patientsV A Koivisto, M Leirisalo-Repo, R Pelkonen, et al.
Acta Endocrinologica|July 1, 1989
Endocrine abnormalities in patients with adrenal tumours incidentally discovered on computed tomographyA Virkkala, M Välimäki, R Pelkonen, et al.
Duodecim; Laaketieteellinen Aikakauskirja|January 1, 1980
[Comparative study on the effects of carbimazole and propranolol in 131I-therapy of hypothyroidism]A Aro, J K Huttunen, E Ikkala, et al.
Diabetologia|August 1, 1984
Remissions in newly diagnosed type 1 (insulin-dependent) diabetes: influence of interferon as an adjunct to insulin therapyV A Koivisto, A Aro, K Cantell, et al.
Acta Endocrinologica|March 1, 1981
Comparison of propranolol and carbimazole as adjuncts to iodine-131 therapy of hyperthyroidismA Aro, J K Huttunen, B A Lamberg, et al.
Diabetes Care|July 1, 1993
Seven years of remission in a type I diabetic patientV A Koivisto, M Leirisalo-Repo, P Ebeling, et al.
Current Drug Metabolism|February 3, 2007
Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liverZoe E Barter, Martin K Bayliss, Philip H Beaune, et al.
Regulatory Toxicology and Pharmacology : RTP|November 30, 2013
PBTK modelling platforms and parameter estimation tools to enable animal-free risk assessment: recommendations from a joint EPAA--EURL ECVAM ADME workshopJos G Bessems, George Loizou, Kannan Krishnan, et al.
Pageof 16